Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients

Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Egerer, Gerlinde (VerfasserIn) , Lehnert, Thomas (VerfasserIn) , Max, Regina (VerfasserIn) , Näher, Helmut (VerfasserIn) , Keilholz, Ulrich (VerfasserIn) , Ho, Anthony Dick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2001
In: International journal of clinical oncology
Year: 2001, Jahrgang: 6, Heft: 1, Pages: 25-28
ISSN:1437-7772
DOI:10.1007/PL00012075
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/PL00012075
Volltext
Verfasserangaben:Gerlinde Egerer, Thomas Lehnert, Regina Max, Helmut Naeher, Ulrich Keilholz, Anthony D. Ho
Beschreibung
Zusammenfassung:Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer.
Beschreibung:Gesehen am 21.12.2021
Beschreibung:Online Resource
ISSN:1437-7772
DOI:10.1007/PL00012075